<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">31559514</PMID><DateRevised><Year>2020</Year><Month>12</Month><Day>01</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">0920-9069</ISSN><JournalIssue CitedMedium="Print"><Volume>71</Volume><Issue>6</Issue><PubDate><Year>2019</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Cytotechnology</Title><ISOAbbreviation>Cytotechnology</ISOAbbreviation></Journal><ArticleTitle>Process optimization for the rapid production of Enterovirus 71.</ArticleTitle><Pagination><StartPage>1053</StartPage><EndPage>1061</EndPage><MedlinePgn>1053-1061</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s10616-019-00340-3</ELocationID><Abstract><AbstractText>Enterovirus 71 (EV71) infection can cause hand-foot-and-mouth disease (HFMD). Inactivated EV71 vaccine was effective to prevent EV71 derived HFMD. A highly efficient and economical process for producing EV71 is needed. In our study, the epidemic strain of EV71 (EV71-2013ZJHFMD) was obtained and purified. The Vero cells were cultured for production of EV71. The mini-bioreactor vessel (Amprotein Inc., China) packed with a 0.6&#xa0;g polymer fiber carrier was used to determine the best seeding cell density, multiplicity of infection (MOI) and temperature. Then the optimized procedure was further applied in a 10&#xa0;L disposable perfusion bioreactor ACPB (AmProtein Current Perfusion Bioreactor). The Vero cell culture and viral titer were monitored. The seeding density of 1.5&#x2009;&#xd7;&#x2009;10<sup>7</sup>&#xa0;cells per 0.6&#xa0;g disk was considered to be the most appropriate for the culture. The best MOI was 0.1 and the temperature was 32&#xa0;&#xb0;C. The total cell number increased from 1.5&#x2009;&#xd7;&#x2009;10<sup>9</sup> to 3.0&#x2009;&#xd7;&#x2009;10<sup>10</sup>. The maximum viral titers reached 1.0&#x2009;&#xd7;&#x2009;10<sup>8</sup>/mL 3&#xa0;days post-infection in our optimized special culture procedure (serum-free during the harvest period, supplemented with 0.25% Lactalbumin Hydrolysate). The total volume of the harvested supernatant was 25&#xa0;L and the total virus yield was 1.93&#x2009;&#xd7;&#x2009;10<sup>12</sup>. The procedure using Vero cells grown on polymer fiber paper carriers was effective for the large-scale production of EV71.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Xiao-Xin</ForeName><Initials>XX</Initials><AffiliationInfo><Affiliation>State Key Laboratory for Diagnosis and Treatment of Infectious Disease, Collaborative Innovative Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, 310003, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Ke-Da</ForeName><Initials>KD</Initials><AffiliationInfo><Affiliation>State Key Laboratory for Diagnosis and Treatment of Infectious Disease, Collaborative Innovative Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, 310003, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Da-Zhi</ForeName><Initials>DZ</Initials><AffiliationInfo><Affiliation>State Key Laboratory for Diagnosis and Treatment of Infectious Disease, Collaborative Innovative Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, 310003, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xiao</LastName><ForeName>Lan-Lan</ForeName><Initials>LL</Initials><AffiliationInfo><Affiliation>State Key Laboratory for Diagnosis and Treatment of Infectious Disease, Collaborative Innovative Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, 310003, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Kai-Zhou</ForeName><Initials>KZ</Initials><AffiliationInfo><Affiliation>State Key Laboratory for Diagnosis and Treatment of Infectious Disease, Collaborative Innovative Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, 310003, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Yan-Jun</ForeName><Initials>YJ</Initials><AffiliationInfo><Affiliation>Department of Virus Inspection, Zhejiang Provincial Center for Disease Control and Prevention, Hangzhou, 310051, China. zhangyjtt@126.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Lan-Juan</ForeName><Initials>LJ</Initials><Identifier Source="ORCID">0000-0001-6945-0593</Identifier><AffiliationInfo><Affiliation>State Key Laboratory for Diagnosis and Treatment of Infectious Disease, Collaborative Innovative Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, 310003, China. ljli@zju.edu.cn.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>2015ZX09101044</GrantID><Agency>State Project of Essential Drug Research and Development</Agency><Country/></Grant><Grant><GrantID>2014C03039</GrantID><Agency>The Science &amp; Technology Key Program of Zhejiang, China</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>09</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Cytotechnology</MedlineTA><NlmUniqueID>8807027</NlmUniqueID><ISSNLinking>0920-9069</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Disposable perfusion bioreactor</Keyword><Keyword MajorTopicYN="N">Enterovirus 71</Keyword><Keyword MajorTopicYN="N">Hand&#x2013;foot-and-mouth disease</Keyword><Keyword MajorTopicYN="N">Mini-bioreactor</Keyword><Keyword MajorTopicYN="N">Polymer fiber paper carriers</Keyword><Keyword MajorTopicYN="N">Vero cells</Keyword></KeywordList><CoiStatement>The authors declare that they have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>11</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>8</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>9</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>9</Month><Day>29</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>9</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2020</Year><Month>12</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31559514</ArticleId><ArticleId IdType="pmc">PMC6874637</ArticleId><ArticleId IdType="doi">10.1007/s10616-019-00340-3</ArticleId><ArticleId IdType="pii">10.1007/s10616-019-00340-3</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Butler M, et al. Application of a serum-free medium for the growth of Vero cells and the production of reovirus. Biotechnol Prog. 2000;16:854&#x2013;858. doi: 10.1021/bp000110+.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/bp000110+</ArticleId><ArticleId IdType="pubmed">11027181</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang LY, et al. Comparison of enterovirus 71 and coxsackie-virus A16 clinical illnesses during the Taiwan enterovirus epidemic, 1998. Pediatr Infect Dis J. 1999;18:1092&#x2013;1096. doi: 10.1097/00006454-199912000-00013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00006454-199912000-00013</ArticleId><ArticleId IdType="pubmed">10608631</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang JY, et al. Selection and characterization of vaccine strain for Enterovirus 71 vaccine development. Vaccine. 2012;30:703&#x2013;711. doi: 10.1016/j.vaccine.2011.11.087.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2011.11.087</ArticleId><ArticleId IdType="pubmed">22142585</ArticleId></ArticleIdList></Reference><Reference><Citation>Chatproedprai S, Theanboonlers A, Korkong S, Thongmee C, Wananukul S, Poovorawan Y. Clinical and molecular characterization of hand&#x2013;foot-and-mouth disease in Thailand, 2008&#x2013;2009. Jpn J Infect Dis. 2010;63:229&#x2013;233.</Citation><ArticleIdList><ArticleId IdType="pubmed">20657060</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen KD, Wu XX, Yu DS, Ou HL, Li YH, Zhou YQ, Li LJ. Process optimization for the rapid production of adenoviral vectors for clinical trials in a disposable bioreactor system. Appl Microbiol Biotechnol. 2018;102:6469&#x2013;6477. doi: 10.1007/s00253-018-9091-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00253-018-9091-5</ArticleId><ArticleId IdType="pubmed">29858958</ArticleId></ArticleIdList></Reference><Reference><Citation>Chong P, et al. Production of EV71 vaccine candidates. Hum Vaccines Immunother. 2012;8:1775&#x2013;1783. doi: 10.4161/hv.21739.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/hv.21739</ArticleId><ArticleId IdType="pmc">PMC3656065</ArticleId><ArticleId IdType="pubmed">22992566</ArticleId></ArticleIdList></Reference><Reference><Citation>Chou AH, et al. Pilot scale production of highly efficacious and stable enterovirus 71 vaccine candidates. PLoS ONE. 2012;7:e34834. doi: 10.1371/journal.pone.0034834.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0034834</ArticleId><ArticleId IdType="pmc">PMC3328501</ArticleId><ArticleId IdType="pubmed">22529942</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao LD, et al. Correlation analysis of EV71 detection and case severity in hand, foot, and mouth disease in the Hunan Province of China. PLoS ONE. 2014;9:e100003. doi: 10.1371/journal.pone.0100003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0100003</ArticleId><ArticleId IdType="pmc">PMC4062471</ArticleId><ArticleId IdType="pubmed">24941257</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu AY, et al. Production of inactivated influenza H5N1 vaccines from MDCK cells in serum-free medium. PLoS ONE. 2011;6:e14578. doi: 10.1371/journal.pone.0014578.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0014578</ArticleId><ArticleId IdType="pmc">PMC3025921</ArticleId><ArticleId IdType="pubmed">21283675</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Y, et al. Characterization of severe hand, foot, and mouth disease in Shenzhen, China, 2009&#x2013;2013. J Med Virol. 2015;87:1471&#x2013;1479. doi: 10.1002/jmv.24200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.24200</ArticleId><ArticleId IdType="pubmed">25951788</ArticleId></ArticleIdList></Reference><Reference><Citation>Iwai M, et al. Genetic changes of coxsackievirus A16 and enterovirus 71 isolated from hand, foot, and mouth disease patients in Toyama, Japan between 1981 and 2007. Jpn J Infect Dis. 2009;62:254&#x2013;259.</Citation><ArticleIdList><ArticleId IdType="pubmed">19628900</ArticleId></ArticleIdList></Reference><Reference><Citation>Li W, et al. Seroprevalence of human enterovirus 71 and coxsackievirus A16 in Guangdong, China, in pre- and post-2010 HFMD epidemic period. PLoS ONE. 2013;8:e80515. doi: 10.1371/journal.pone.0080515.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0080515</ArticleId><ArticleId IdType="pmc">PMC3850913</ArticleId><ArticleId IdType="pubmed">24324604</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin YC, Wu CN, Shih SR, Ho MS. Characterization of a Vero cell-adapted virulent strain of enterovirus 71 suitable for use as a vaccine candidate. Vaccine. 2002;20:2485&#x2013;2493. doi: 10.1016/S0264-410X(02)00182-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0264-410X(02)00182-2</ArticleId><ArticleId IdType="pubmed">12057603</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu CC, Lian WC, Butler M, Wu SC. High immunogenic enterovirus 71 strain and its production using serum-free microcarrier Vero cell culture. Vaccine. 2007;25:19&#x2013;24. doi: 10.1016/j.vaccine.2006.06.083.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2006.06.083</ArticleId><ArticleId IdType="pubmed">16919374</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu CC, et al. Purification and characterization of enterovirus 71 viral particles produced from vero cells grown in a serum-free microcarrier bioreactor system. PLoS ONE. 2011;6:e20005. doi: 10.1371/journal.pone.0020005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0020005</ArticleId><ArticleId IdType="pmc">PMC3094384</ArticleId><ArticleId IdType="pubmed">21603631</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu W, et al. Spatiotemporal dynamics of hand-foot-mouth disease and its relationship with meteorological factors in Jiangsu Province, China. PLoS ONE. 2015;10:e0131311. doi: 10.1371/journal.pone.0131311.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0131311</ArticleId><ArticleId IdType="pmc">PMC4488144</ArticleId><ArticleId IdType="pubmed">26121573</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma S, et al. Dynamic constitution of the pathogens inducing encephalitis in hand, foot and mouth disease in Kunming, 2009&#x2013;2011. Jpn J Infect Dis. 2015;68:504&#x2013;510. doi: 10.7883/yoken.JJID.2014.428.</Citation><ArticleIdList><ArticleId IdType="doi">10.7883/yoken.JJID.2014.428</ArticleId><ArticleId IdType="pubmed">25866107</ArticleId></ArticleIdList></Reference><Reference><Citation>Solomon T, Lewthwaite P, Perera D, Cardosa MJ, McMinn P, Ooi MH. Virology, epidemiology, pathogenesis, and control of enterovirus 71. Lancet Infect Dis. 2010;10:778&#x2013;790. doi: 10.1016/S1473-3099(10)70194-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(10)70194-8</ArticleId><ArticleId IdType="pubmed">20961813</ArticleId></ArticleIdList></Reference><Reference><Citation>Takahashi S, et al. Hand, foot, and mouth disease in China: modeling epidemic dynamics of enterovirus serotypes and implications for vaccination. PLoS Med. 2016;13:e1001958. doi: 10.1371/journal.pmed.1001958.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1001958</ArticleId><ArticleId IdType="pmc">PMC4755668</ArticleId><ArticleId IdType="pubmed">26882540</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Tu P, et al. Epidemiologic and virologic investigation of hand, foot, and mouth disease, southern Vietnam, 2005. Emerg Infect Dis. 2007;13:1733&#x2013;1741. doi: 10.3201/eid1311.070632.</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid1311.070632</ArticleId><ArticleId IdType="pmc">PMC3375788</ArticleId><ArticleId IdType="pubmed">18217559</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu SC, Liu CC, Lian WC. Optimization of microcarrier cell culture process for the inactivated enterovirus type 71 vaccine development. Vaccine. 2004;22:3858&#x2013;3864. doi: 10.1016/j.vaccine.2004.05.037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2004.05.037</ArticleId><ArticleId IdType="pubmed">15364432</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu CY, et al. Inactivated enterovirus 71 vaccine produced by 200-L scale serum-free microcarrier bioreactor system provides cross-protective efficacy in human SCARB2 transgenic mouse. PLoS ONE. 2015;10:e0136420. doi: 10.1371/journal.pone.0136420.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0136420</ArticleId><ArticleId IdType="pmc">PMC4543551</ArticleId><ArticleId IdType="pubmed">26287531</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao X, et al. Comparisons between mild and severe cases of hand, foot and mouth disease in temporal trends: a comparative time series study from mainland China. BMC Public Health. 2016;16:1109. doi: 10.1186/s12889-016-3762-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12889-016-3762-x</ArticleId><ArticleId IdType="pmc">PMC5073464</ArticleId><ArticleId IdType="pubmed">27769194</ArticleId></ArticleIdList></Reference><Reference><Citation>Xing W, et al. Hand, foot, and mouth disease in China, 2008&#x2013;12: an epidemiological study. Lancet Infect Dis. 2014;14:308&#x2013;318. doi: 10.1016/S1473-3099(13)70342-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(13)70342-6</ArticleId><ArticleId IdType="pmc">PMC4035015</ArticleId><ArticleId IdType="pubmed">24485991</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu W, et al. Distribution of enteroviruses in hospitalized children with hand, foot and mouth disease and relationship between pathogens and nervous system complications. Virol J. 2012;9:8. doi: 10.1186/1743-422X-9-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1743-422X-9-8</ArticleId><ArticleId IdType="pmc">PMC3268717</ArticleId><ArticleId IdType="pubmed">22230340</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang B, Wu P, Wu JT, Lau EH, Leung GM, Yu H, Cowling BJ. Seroprevalence of enterovirus 71 antibody among children in China: a systematic review and meta-analysis. Pediatr Infect Dis J. 2015;34:1399&#x2013;1406. doi: 10.1097/INF.0000000000000900.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/INF.0000000000000900</ArticleId><ArticleId IdType="pmc">PMC4718881</ArticleId><ArticleId IdType="pubmed">26368058</ArticleId></ArticleIdList></Reference><Reference><Citation>Yin XG, Yi HX, Shu J, Wang XJ, Wu XJ, Yu LH. Clinical and epidemiological characteristics of adult hand, foot, and mouth disease in northern Zhejiang, China, May 2008&#x2013;November 2013. BMC Infect Dis. 2014;14:251. doi: 10.1186/1471-2334-14-251.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2334-14-251</ArticleId><ArticleId IdType="pmc">PMC4026826</ArticleId><ArticleId IdType="pubmed">24885052</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao J, Jiang F, Zhong L, Sun J, Ding J. Age patterns and transmission characteristics of hand, foot and mouth disease in China. BMC Infect Dis. 2016;16:691. doi: 10.1186/s12879-016-2008-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-016-2008-y</ArticleId><ArticleId IdType="pmc">PMC5117511</ArticleId><ArticleId IdType="pubmed">27871252</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Y, Li JX, Jin PF, Wang YX, Zhu FC. Enterovirus 71: a whole virion inactivated enterovirus 71 vaccine. Expert Rev Vaccines. 2016;15:803&#x2013;813. doi: 10.1080/14760584.2016.1191357.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14760584.2016.1191357</ArticleId><ArticleId IdType="pubmed">27206811</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>